Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
ExecuPharm (India) Private Limited, headquartered in India, is a prominent player in the clinical research and pharmaceutical services industry. Founded in 2000, the company has established itself as a trusted partner for biopharmaceutical organisations, offering a comprehensive range of services including clinical trial management, regulatory affairs, and data management.
With a strong operational presence across major regions in India, ExecuPharm is renowned for its commitment to quality and innovation. The company’s unique approach combines local expertise with global standards, ensuring efficient and effective solutions tailored to client needs. Notable achievements include successful collaborations with leading pharmaceutical companies, positioning ExecuPharm as a key contributor to the advancement of healthcare in the region.
No reported emissions data is available for ExecuPharm (India) Private Limited yet.
ExecuPharm (India) Private Limited currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Parexel International Corporation, which may influence its climate commitments and emissions reporting.
As part of its corporate family, ExecuPharm inherits climate initiatives and targets from Parexel International Corporation. However, there are no documented reduction targets or climate pledges specific to ExecuPharm (India) Private Limited. The absence of specific data suggests that the company may still be in the process of establishing its own emissions reduction strategies or may rely on the broader initiatives set by its parent organisation.
In summary, while ExecuPharm (India) Private Limited does not currently report specific emissions data or reduction targets, it is positioned within a corporate structure that may provide a framework for future climate commitments through its relationship with Parexel International Corporation.
No climate goals have been disclosed for ExecuPharm (India) Private Limited yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for ExecuPharm (India) Private Limited yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more